RLY-2608

DB16751InvestigationalSmall molecule

RLY-2608: Overview.

Mechanism: Pharmacologically active on Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform
Curator reviewed
Code names: RLY-2608

Resolves to

Compound

Targets

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with RLY-2608, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.